Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemilukast in exercise-induced bronchoconstriction
NCT01536041Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemilukast in Exercise-induced bronchoconstriction (EIB), sponsored by Ono Pharmaceutical. Started Mar 2012; status: completed.
02
Drugs
gemilukast
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT01536041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536041.